Try our Advanced Search for more refined results
Rankings: MVPs of the Year
-
November 25, 2024
MVP: Cooley's Lila Hope
Lila Hope of Cooley LLP shepherded SystImmune Inc.'s $8.4 billion collaboration with Bristol Myers Squibb Co. and advised Foreseen Biotechnology on its $1 billion licensing agreement with Ipsen, earning her a spot among the 2024 Law360 Life Sciences MVPs.
-
November 22, 2024
MVP: Skadden's Graham Robinson
Graham Robinson of Skadden Arps Slate Meagher & Flom LLP represented Iveric Bio in its $5.9 billion sale to global pharmaceutical company Astellas Pharma Inc., earning him a spot among the 2024 Law360 Life Sciences MVPs.
-
November 21, 2024
MVP: Fenwick's Douglas Cogen
Douglas Cogen of Fenwick & West LLP's life sciences practice guided cardiovascular device company Shockwave Medical through a record-breaking acquisition by Johnson & Johnson, while he simultaneously shepherded multiple biopharma companies through multibillion-dollar deals, earning him recognition as a 2024 Law360 Life Sciences MVPs.
-
November 20, 2024
MVP: Williams & Connolly's David I. Berl
David I. Berl of Williams & Connolly LLP's patent litigation practice helped win a first-of-its-kind trial victory on behalf of Regeneron Pharmaceuticals by employing a novel legal strategy that allowed the biotech giant to quickly adjudicate its patent rights to an eye care medicine, earning him a spot as one of the 2024 Law360 Life Sciences MVPs.
-
November 19, 2024
MVP: Covington's Catherine Dargan
Catherine Dargan of Covington & Burling LLP represented Bristol Myers Squibb Co. in its $14 billion acquisition of the company that developed Cobenfy — the first new drug in 35 years to be approved by the Food and Drug Administration for treating schizophrenia — earning her a spot among the 2024 Law360 Life Sciences MVPs.
-
November 18, 2024
MVP: Ropes & Gray's Amanda Austin
Amanda Austin of Ropes & Gray's life sciences practice guided Pfizer through its $7 billion deal with Flagship Pioneering, advised Fulcrum Therapeutics in its blockbuster collaboration with Sanofi, and was lead counsel to Ginkgo Bioworks, earning her a spot as one of the 2024 Law360 Life Sciences MVPs.
-
October 18, 2024
Law360 MVP Awards Go To Top Attys From 74 Firms
The attorneys chosen as Law360's 2024 MVPs have distinguished themselves from their peers by securing hard-earned successes in high-stakes litigation, complex global matters and record-breaking deals.
-
October 20, 2023
MVP: Winston & Strawn's George Lombardi
George Lombardi of Winston & Strawn LLP has spent most of the last year in trials, collecting a number of wins and earning himself a spot among Law360's 2023 Life Sciences MVPs.
-
October 19, 2023
MVP: Sullivan & Cromwell's Matt Hurd
Matt Hurd of Sullivan & Cromwell LLP recently led Pfizer's acquisition of Seagen, a global biotech company specializing in cancer medicines, in a $43 billion all-cash deal, earning him a spot among Law360's 2023 Life Sciences MVPs.
-
October 18, 2023
MVP: Paul Weiss' Krishna Veeraraghavan
Krishna Veeraraghavan of Paul Weiss Rifkind Wharton & Garrison LLP is leading home health provider Amedisys Inc. in its $3.3 billion acquisition by a UnitedHealth Group subsidiary and advised Amazon in its $3.9 billion acquisition of One Medical, earning him a spot among Law360's 2023 Life Sciences MVPs.
-
October 17, 2023
MVP: Paul Hastings' Eric Dittmann
Eric Dittmann of Paul Hastings LLP shepherded Mitsubishi Tanabe Pharma Corp. through its win over Novartis Pharma AG after a four-year multibillion-dollar royalty battle and represented L'Oreal in protecting its skincare business after a suit filed by the University of Massachusetts Medical School and Carmel Laboratories threatened 180 products, earning him a spot as one of Law360's 2023 Life Sciences MVPs.
-
October 16, 2023
MVP: Davis Polk's David Bauer
David Bauer of Davis Polk & Wardwell LLP advised Cellular Biomedicine Group on its licensing agreement with Janssen, in order to bring new cancer treatments outside of China, which earned him a spot among Law360's 2023 Life Sciences MVPs.
-
October 01, 2023
Law360 MVP Awards Go To 171 Attys At 76 Firms
The attorneys chosen as Law360's 2023 MVPs have distinguished themselves from their peers by securing hard-earned successes in high-stakes litigation, complex global matters and record-breaking deals.
-
September 28, 2022
MVP: Williams & Connolly's David I. Berl
David Berl of Williams & Connolly LLP has spent much of the last year arguing and winning before the Federal Circuit, including securing an appellate win for AstraZeneca over a generic-drug dispute for its flagship asthma drug Symbicort, earning him a spot among Law360's 2022 Life Sciences MVPs.
-
September 27, 2022
MVP: White & Case's Adam Acosta
Adam Acosta of White & Case LLP's life sciences practice has guided various health care giants through high-stakes litigation, including helping client AbbVie Inc. escape two antitrust class action complaints over hypertension medication Bystolic, earning him a spot among Law360's 2022 Life Sciences MVPs.
-
September 26, 2022
MVP: Quinn Emanuel's David Bilsker And David Perlson
As a pair, David Bilsker and David Perlson of Quinn Emanuel Urquhart & Sullivan LLP spent the last year at the helm of a Chinese biotech giant's legal war over DNA patents against Illumina, earning them a spot among Law360's 2022 Life Science MVPs.
-
September 23, 2022
MVP: Covington's Amy Toro
Throughout the past year, Amy L. Toro of Covington & Burling LLP led life sciences companies like Sanofi and AstraZeneca through deals worth well into the billions, earning her a spot among Law360's 2022 Life Sciences MVPs.
-
September 02, 2022
Law360 MVP Awards Go To 188 Attys From 78 Firms
The attorneys chosen as Law360's 2022 MVPs have distinguished themselves from their peers by securing hard-earned successes in high-stakes litigation, complex global matters and record-breaking deals.
-
September 23, 2021
MVP: Cohen Milstein's Sharon K. Robertson
Sharon Robertson of Cohen Milstein Sellers & Toll PLLC has waged a number of legal battles in pay-for-delay schemes this year, earning her a spot among Law360's 2021 Life Sciences MVPs.
-
September 22, 2021
MVP: Keker Van Nest's Laurie Mims
Laurie Mims of Keker Van Nest & Peters LLP led a trial team that won former shareholders of FerroKin Biosciences more than $80 million in a post-merger dispute with Shire Pharmaceuticals, earning her a spot as one of Law360's 2021 Life Sciences MVPs.
-
September 21, 2021
MVP: Skadden's Jennifer Bragg
Skadden Arps Slate Meagher & Flom LLP partner Jennifer Bragg was part of the legal team that negotiated Purdue Pharma's guilty plea with the U.S. Department of Justice over its illegal marketing of opioids and helped a testing lab beat a $178 million whistleblower suit, earning her a spot as one of Law360's 2021 Life Sciences MVPs.
-
September 20, 2021
MVP: Gibson Dunn's Jane M. Love, Ph.D.
Gibson Dunn & Crutcher LLP partner Jane Love, Ph.D., helped Novartis Pharmaceuticals Corp. beat a challenge to its blockbuster multiple sclerosis drug Gilenya in a Delaware federal court case, earning her a spot among Law360's 2021 Life Sciences MVPs.
-
September 17, 2021
MVP: Ropes & Gray's Hannah H. England (Freeman)
Hannah H. England (Freeman) of Ropes & Gray LLP has advised on a number of complex transactions in the biopharma sector, including UniQure's licensing deal with CSL Behring over gene therapy for patients with hemophilia B, earning her a spot among Law360's 2021 Life Sciences MVPs.
-
August 30, 2021
Law360 MVP Awards Go To 182 Attys From 77 Firms
The elite slate of attorneys chosen as Law360's 2021 MVPs have distinguished themselves from their peers by securing hard-earned successes in high-stakes litigation, complex global matters and record-breaking deals.
-
October 09, 2020
MVP: White & Case's Robert Milne
White & Case LLP's Robert Milne led Hospira Inc. to victory in high-stakes litigation over alleged collusion to artificially reduce the supply of IV saline and guided Pfizer out of a bellwether biosimilar antitrust class action, making him one of Law360's 2020 Life Sciences MVPs.